| Riverview Pharmacy | |
| 475 Brown Blvd, Ste 105, Bourbonnais, Illinois 60914 | |
| (815) 933-1735 |
| Name | Riverview Pharmacy |
|---|---|
| Organization Name | Riverview Pharmacies, Inc. |
| Location | 475 Brown Blvd, Ste 105, Bourbonnais, Illinois 60914 |
| Type | Pharmacy |
| Phone | (815) 933-1735 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
ADVENTRX Pharmaceuticals has announced positive results from preclinical studies using a multidrug treatment regimen including ANX-510 (CoFactor) at the American Association for Cancer Research (AACR) Annual Meeting.
Dr. Peter J. Hotez, an internationally recognized clinician and investigator of neglected tropical diseases and vaccine development, will be giving a lecture at the University of Houston (UH) from 3 to 4 p.m. Friday, Feb. 10. Hotez is one of many prominent scientists with broad appeal who will be hosted by UH in support of the university's health initiative. The talk is free and open to the public.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
› Verified 4 days ago
| NPI Number | 1588779516 |
| Organization Name | RIVERVIEW PHARMACIES INC |
| Doing Business As | RIVERVIEW PHARMACY |
| Type | Pharmacy |
| Address | 475 Brown Blvd, Suite 105, Bourbonnais, IL 60914 |
| Phone Number | 815-933-1735 |
News Archive
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
ADVENTRX Pharmaceuticals has announced positive results from preclinical studies using a multidrug treatment regimen including ANX-510 (CoFactor) at the American Association for Cancer Research (AACR) Annual Meeting.
Dr. Peter J. Hotez, an internationally recognized clinician and investigator of neglected tropical diseases and vaccine development, will be giving a lecture at the University of Houston (UH) from 3 to 4 p.m. Friday, Feb. 10. Hotez is one of many prominent scientists with broad appeal who will be hosted by UH in support of the university's health initiative. The talk is free and open to the public.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
› Verified 4 days ago
| NPI Number | 1932839537 |
| Organization Name | RIVERVIEW PHARMACIES INC |
| Doing Business As | RIVERVIEW PHARMACY LTC/RIVERVIEW PHARMACY INC |
| Type | Long Term Care Pharmacy |
| Address | 475 Brown Blvd Ste 105, Bourbonnais, IL 60914 |
| Phone Number | 815-933-1735 |
News Archive
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
ADVENTRX Pharmaceuticals has announced positive results from preclinical studies using a multidrug treatment regimen including ANX-510 (CoFactor) at the American Association for Cancer Research (AACR) Annual Meeting.
Dr. Peter J. Hotez, an internationally recognized clinician and investigator of neglected tropical diseases and vaccine development, will be giving a lecture at the University of Houston (UH) from 3 to 4 p.m. Friday, Feb. 10. Hotez is one of many prominent scientists with broad appeal who will be hosted by UH in support of the university's health initiative. The talk is free and open to the public.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
› Verified 4 days ago
News Archive
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
ADVENTRX Pharmaceuticals has announced positive results from preclinical studies using a multidrug treatment regimen including ANX-510 (CoFactor) at the American Association for Cancer Research (AACR) Annual Meeting.
Dr. Peter J. Hotez, an internationally recognized clinician and investigator of neglected tropical diseases and vaccine development, will be giving a lecture at the University of Houston (UH) from 3 to 4 p.m. Friday, Feb. 10. Hotez is one of many prominent scientists with broad appeal who will be hosted by UH in support of the university's health initiative. The talk is free and open to the public.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
› Verified 4 days ago
Osco Drug #2488 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 655 Main St, Bourbonnais, Illinois 60914 Phone: (815) 929-0590 | |
Fisher-swale-nicholson Eye Center S Type: Medicare Supplier Location: 352 Brown Blvd, Bourbonnais, Illinois 60914 Phone: (815) 932-2020 | |
Cvs Pharmacy #16327 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1615 N State Route 50, Bourbonnais, Illinois 60914 Phone: (815) 933-1777 | |
Kinetic O&p Ltd Type: Prosthetic/Orthotic Supplier Location: 453 S Main Street, Bourbonnais, Illinois 60914 Phone: (815) 401-7260 | |
Kroger Pharmacy #984 Type: Community/Retail Pharmacy Location: 633 Armour Rd, Bourbonnais, Illinois 60914 Phone: (815) 935-1653 |